Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001695028-26-000012

Chief Financial Officer sold 14,000 shares at $13.53 ($189,391)

  • Chief Financial Officer acquired 14,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Piscitelli Dominic · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-20 Exercise or conversion : show line 1 in the form 10b5-1 +14,000 $4.36 $61,040 83,828 D
2026-10-20 Sale : show line 2 in the form 10b5-1 −14,000 $13.53 $189,391 69,828 D
Open-market sales · 14,000 sh · avg $13.53 · $189,391

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-20 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −14,000 64,500 D
Loading xslF345X06/form4-10212026_091012.xml…